Federal Government Scrutinizing Sales Rep Dealings With Trial Results
This article was originally published in The Gray Sheet
Executive Summary
Medical device manufacturers who let their sales representatives disseminate clinical trial results for unapproved devices or off-label indications are skating on thin ice, according to the Department of Justice and the HHS Office of Inspector General